We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hydrogen Inhalation Ameliorates Ventilator-Induced Lung Injury

By HospiMedica International staff writers
Posted on 13 Jan 2011
A new study has found that inhaled hydrogen gas effectively reduces ventilator-induced lung injury (VILI)-associated inflammatory responses, at both a local and systemic level. More...


Researchers at the University of Pittsburgh Medical Center (UPMC; PA, USA), the Taiwanese National Yang-Ming University School of Medicine (Taipei), and other institutions hypothesized that inhaled hydrogen therapy could ameliorate VILI, due to its antioxidant, anti-inflammatory, and antiapoptotic properties. To test the hypothesis, VILI was generated in male mice by performing a tracheostomy and placing the mice on mechanical ventilation (MV).The mice were randomly assigned to treatment groups and subjected to VILI with delivery of either 2% nitrogen or 2% hydrogen in air. Sham animals were given same gas treatments for two hours. The effects of VILI induced by less invasive and longer exposure to MV were also investigated.

The results showed that ventilation at 30 mL/kg with 2% nitrogen in air for 2 hours resulted in deterioration of lung function, increased lung edema, and infiltration of inflammatory cells. In contrast, ventilation with 2% hydrogen in air significantly ameliorated these acute lung injuries. Hydrogen treatment also significantly inhibited upregulation of mRNA proinflammatory mediators and induced antiapoptotic genes. In the lungs treated with hydrogen, there was less malondialdehyde compared with lungs treated with nitrogen. Similarly, longer exposure to MV within lower tidal volume caused lung injury, including bronchial epithelial apoptosis; hydrogen improved gas exchange and reduced VILI-induced apoptosis. The study was published on December 25, 2010, in Critical Care.

"Although extensive studies on toxicity and safety are needed, hydrogen treatment of ventilated patients may be clinically feasible and would be easy to incorporate without alteration of interventional and surgical procedures,” concluded lead author Chien-Sheng Huang, MD, of the UPMC department of cardiothoracic surgery, and colleagues.

Hydrogen is a stable molecule and does not react with other therapeutic medical gases at room temperature; thus, it may be administered as a combined gas with other therapeutic gases, or with inhaled anesthesia agents. Inhaled hydrogen gas has been safely utilized for treatment of decompression syndrome in divers, suggesting that hydrogen can be safely administered to patients.

Related Links:
University of Pittsburgh Medical Center
Taiwan National Yang-Ming University School of Medicine


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Medical-Grade Display
HL2316SHTB
New
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.